Corporate ActionMay 1, 2026, 03:32 PM
Profusa Registers 179.27M Shares for Resale; Secures $100M Equity Facility
AI Summary
Profusa, Inc. filed an S-1 amendment to register 179,272,293 shares of common stock for resale by selling stockholders, including Ascent Partners Fund LLC and NorthView Sponsor I, LLC. This registration facilitates the potential sale of up to $100 million in common stock to Ascent under an Equity Line of Credit (ELOC) agreement and the conversion of approximately $8.9 million in convertible notes. Additionally, the company secured an exclusive license agreement with Mayo Clinic for continuous oxygen measurement technology and received forgiveness for a $1.3 million PPP loan.
Key Highlights
- Registers 179,272,293 common shares for resale by selling stockholders.
- Includes 150,568,827 shares for Ascent under a $100,000,000 ELOC Purchase Agreement.
- Includes 20,027,859 shares for Ascent from conversion of $7.0M in Ascent Notes.
- Includes 5,342,274 shares for Sponsor from conversion of $1.9M in Sponsor Notes.
- Issued Ascent Inducement Warrant for 3,333,333 shares at $0.50 exercise price.
- Entered exclusive license agreement with Mayo Clinic for continuous oxygen measurement.
- Received forgiveness for a $1,304,996.05 PPP loan.
- Effected a 1-for-75 reverse stock split on February 9, 2026.